Geode Capital Management’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-969,950
| Closed | -$18.3M | – | 4303 |
|
|
2019
Q3 | $18.3M | Buy |
969,950
+25,606
| +3% | +$483K | ﹤0.01% | 1548 |
|
|
2019
Q2 | $11.1M | Buy |
944,344
+76,209
| +9% | +$897K | ﹤0.01% | 1874 |
|
|
2019
Q1 | $11.9M | Buy |
868,135
+219,695
| +34% | +$3M | ﹤0.01% | 1778 |
|
|
2018
Q4 | $6.65M | Buy |
648,440
+29,296
| +5% | +$300K | ﹤0.01% | 2047 |
|
|
2018
Q3 | $10.3M | Buy |
619,144
+23,018
| +4% | +$383K | ﹤0.01% | 1894 |
|
|
2018
Q2 | $9.42M | Buy |
596,126
+25,337
| +4% | +$400K | ﹤0.01% | 1913 |
|
|
2018
Q1 | $7.25M | Buy |
570,789
+10,939
| +2% | +$139K | ﹤0.01% | 2001 |
|
|
2017
Q4 | $6.41M | Buy |
559,850
+43,864
| +9% | +$502K | ﹤0.01% | 2067 |
|
|
2017
Q3 | $6.32M | Buy |
515,986
+99,093
| +24% | +$1.21M | ﹤0.01% | 2058 |
|
|
2017
Q2 | $4.77M | Buy |
416,893
+15,323
| +4% | +$175K | ﹤0.01% | 2173 |
|
|
2017
Q1 | $8.35M | Buy |
401,570
+70,691
| +21% | +$1.47M | ﹤0.01% | 1741 |
|
|
2016
Q4 | $6.88M | Buy |
330,879
+4,153
| +1% | +$86.4K | ﹤0.01% | 1846 |
|
|
2016
Q3 | $10.7M | Buy |
326,726
+253
| +0.1% | +$8.29K | 0.01% | 1450 |
|
|
2016
Q2 | $8.15M | Buy |
326,473
+147,236
| +82% | +$3.68M | ﹤0.01% | 1584 |
|
|
2016
Q1 | $4.39K | Buy |
179,237
+3,621
| +2% | +$89 | ﹤0.01% | 1955 |
|
|
2015
Q4 | $5.8M | Sell |
175,616
-9,425
| -5% | -$311K | ﹤0.01% | 1773 |
|
|
2015
Q3 | $6.06M | Buy |
185,041
+62,144
| +51% | +$2.04M | ﹤0.01% | 1712 |
|
|
2015
Q2 | $6.51M | Buy |
122,897
+14,986
| +14% | +$794K | ﹤0.01% | 1724 |
|
|
2015
Q1 | $3.11M | Buy |
107,911
+55,184
| +105% | +$1.59M | ﹤0.01% | 2156 |
|
|
2014
Q4 | $1.53M | Buy |
52,727
+13,785
| +35% | +$401K | ﹤0.01% | 2594 |
|
|
2014
Q3 | $493K | Buy |
38,942
+194
| +0.5% | +$2.46K | ﹤0.01% | 3178 |
|
|
2014
Q2 | $777K | Buy |
+38,748
| New | +$777K | ﹤0.01% | 2946 |
|